NYSE:AGL - US00857U1079 - Common Stock
We assign a fundamental rating of 3 out of 10 to AGL. AGL was compared to 101 industry peers in the Health Care Providers & Services industry. The financial health of AGL is average, but there are quite some concerns on its profitability. AGL is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -18.43% | ||
ROE | -77.19% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 0.5% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.73 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.16 | ||
Quick Ratio | 1.16 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
1.23
-0.15 (-10.87%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.09 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.25 | ||
P/tB | 1.6 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -18.43% | ||
ROE | -77.19% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 0.5% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 125.46% | ||
Cap/Sales | 0.57% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.16 | ||
Quick Ratio | 1.16 | ||
Altman-Z | 1.73 |